Leukemia Clinical Trials in Maryland

Showing 1361-1380 of 1,903 trials

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

NCT00548093

To assess the antitumor efficacy measured by the objective response rate of oral PF-00299804 taken daily, as single agent in patients with advanced NSCLC who failed at least one chemotherapy + erlotinib.

Carcinoma, Non Small Cell Lung

Pfizer66 participantsStarted Apr 2008

Duarte, California, United States • Pasadena, California, United States • South Pasadena, California, United States +16 more locations

COMPLETEDPhase 117 miles

A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia

NCT00586924

A dose-escalation study to identify the dose-limiting toxicity (DLT) and maximum tolerated dose (MTD), defined as the highest dose that can safely be given to a participant and establish the safest dose based on the highest tolerated dose for clinical testing.

Hairy Cell Leukemia

MedImmune LLC49 participantsStarted May 2007

Stanford, California, United States • Chicago, Illinois, United States • Bethesda, Maryland, United States +1 more locations

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia

Leukemia Trials in Other Cities

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Dietary Interventions in Asthma Treatment: Sprouts Study

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Early Diagnosis of Candidiasis in Premature Infants

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Frequency of Screening and SBT Technique Trial

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

Comparability and Standardization of Controlled Allergen Challenge Facilities

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

A Study for Patients With Acute Leukemia

Other Conditions in Maryland